Landmark Clinical Trials in Retinal Vein Occlusion: Delivering Evidence-Based Care in Windsor and Berkshire

Retinal vein occlusion (RVO) is one of the most common retinal vascular disorders and a leading cause of sudden, painless vision loss. It occurs when a vein draining blood from the retina becomes blocked, leading to retinal swelling (macular oedema), bleeding, and reduced vision. Prompt diagnosis and specialist treatment are essential, as early intervention offers the greatest opportunity to preserve and improve sight.

Over the past two decades, several landmark clinical trials have transformed the management of retinal vein occlusion. Pivotal studies including BRAVO and CRUISE demonstrated that anti-VEGF therapy significantly improves vision in patients with branch and central retinal vein occlusion, respectively. The COPERNICUS and GALILEO trials further confirmed the benefits of early treatment for central retinal vein occlusion, while SCORE2 established that different anti-VEGF agents can achieve comparable visual outcomes when used appropriately. Collectively, these studies have established the international standard of care for treating retinal vein occlusion and have dramatically improved the outlook for patients.

Mr Kumar's approach to retinal vein occlusion is firmly grounded in this high-quality clinical evidence. As an experienced retina specialist, he combines the findings of these landmark trials with detailed retinal imaging, including optical coherence tomography (OCT), to develop an individualised treatment plan for every patient. No two eyes are the same, and treatment decisions are carefully tailored according to the type of retinal vein occlusion, the severity of macular oedema, visual requirements, and the patient's overall health.

Patients attending Mr Kumar's clinics in Windsor, Berkshire, and the surrounding Thames Valley receive comprehensive assessment, timely treatment, and close follow-up. Anti-VEGF injections are recommended where clinically appropriate, with ongoing monitoring to ensure treatment is adjusted according to the eye's response. This personalised, evidence-based approach helps maximise visual recovery while reducing the risk of long-term retinal damage.

If you have experienced sudden blurred vision or have been diagnosed with a retinal vein occlusion, early assessment by an experienced retinal specialist is vital. By applying the best available scientific evidence alongside modern imaging technology and personalised care, Mr Kumar aims to achieve the best possible visual outcomes and help patients preserve their sight for the future.